Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 4/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2415717 | 1.00 | LMNA (0.46) | LMNADNM1CA2TSHRTHRB | |
| SCHEMBL2410821 | 1.00 | LMNA (0.46) | LMNADNM1CA2TSHRTHRB | |
| SCHEMBL2410999 | 1.00 | LMNA (0.46) | LMNADNM1CA2TSHRTHRB | |
| SCHEMBL2410330 | 1.00 | LMNA (0.46) | LMNADNM1CA2TSHRTHRB | |
| SCHEMBL11824161 | 1.00 | LMNA (0.46) | LMNADNM1CA2TSHRTHRB | |
| SCHEMBL11819975 | 1.00 | LMNA (0.46) | LMNADNM1CA2TSHRTHRB | |
| SCHEMBL2411117 | 1.00 | LMNA (0.46) | LMNADNM1CA2TSHRTHRB | |
| SCHEMBL11819499 | 1.00 | LMNA (0.46) | LMNADNM1CA2TSHRTHRB | |
| SCHEMBL11819295 | 0.98 | LMNA (0.45) | LMNADNM1CA2TSHRTHRB | |
| SCHEMBL11819591 | 0.96 | LMNA (0.43) | LMNADNM1CA2TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017677-B2 | Plasticizer for resin and resin composition containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20100022692-A1 | PLASTICIZER FOR RESIN AND RESIN COMPOSITION CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2098563-A1 | PLASTICIZER FOR RESIN AND RESIN COMPOSITION CONTAINING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2009-09-09 | — | — | EP | disclosed |
| US-3939084-A | Functional fluid compositions containing substituted pyrimidines | MONSANTO COMPANY (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022692-A1 | PLASTICIZER FOR RESIN AND RESIN COMPOSITION CONTAINING THE SAME | ALOX5, ALOX12, ALOX15 | LMNA 3395/4885DNM1 3351/4885CA2 4540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.